Rezolute (RZLT) Times Interest Earned (2012 - 2019)
Rezolute (RZLT) posted Times Interest Earned of -$5.11 for Q1 2026, up 47.28% sequentially from -$9.69 in Q4 2025, and down 7.14% YoY from -$5.5 in Q1 2025.
Powered by 
Analysis
Rezolute (RZLT) Times Interest Earned (2012 - 2019) Analysis & Trends
Rezolute has reported Times Interest Earned for 15 years, with the latest figure at -$5.11 in Q1 2026.
- Quarterly Times Interest Earned fell 7.14% year-over-year to -$5.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.66 (down 39.71% YoY) and the FY2025 annual result came in at -$0.89, up 81.58% from the prior year.
- Times Interest Earned rose to -$5.11 in Q1 2026 per RZLT's latest filing, from -$9.69 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.27 in Q3 2025 and troughed at -$136.77 in Q2 2025.
- A 5-year average of -$35.16 and a median of -$15.36 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned soared 97.97% in 2024, then plunged 989.09% in 2025.
- Over 5 years, Times Interest Earned stood at -$24.07 in 2022, then sank by 82.46% to -$43.91 in 2023, then jumped by 97.97% to -$0.89 in 2024, then slumped by 989.09% to -$9.69 in 2025, then jumped by 47.28% to -$5.11 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$5.11, -$9.69, and -$0.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 1.42 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -0.08 |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -0.74 |
| Mar 31, 2019 | -2.89 |
| Dec 31, 2018 | -2.45 |
| Sep 30, 2018 | -2.81 |
| Jun 30, 2018 | -17.80 |
| Mar 31, 2018 | -92.83 |
| Dec 31, 2017 | -39,122.16 |
| Sep 30, 2016 | -2,397.29 |
| Jun 30, 2016 | -4,280.62 |
| Mar 31, 2016 | -3,250.63 |
| Dec 31, 2015 | -2,948.90 |
| Sep 30, 2015 | -2,045.69 |
| Jun 30, 2015 | -1,677.62 |
| Mar 31, 2015 | -1,102.68 |
| Dec 31, 2014 | -1,334.94 |
| Sep 30, 2014 | -4,470.24 |
| Jun 30, 2014 | -4,459.43 |
| Mar 31, 2014 | -0.46 |
| Dec 31, 2013 | -1.04 |
| Sep 30, 2013 | -4.25 |